Seascape Capital Management Edwards Lifesciences Corp Transaction History

Seascape Capital Management

$280 Million
Q3 2024

A detailed history of Seascape Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Seascape Capital Management holds 32,989 shares of EW stock, worth $2.47 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

32,989

Previous 32,815 0.53%

Holding current value

$2.47 Million

Previous $3.03 Million 28.18%

% of portfolio

0.78%

Previous 1.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$59.7 - $93.78 $10,387 - $16,317	174 Added 0.53%	32,989 $2.18 Million
Q2 2024 Jul 30, 2024	BUY	$84.3 - $94.31 $139,769 - $156,365	1,658 Added 5.32%	32,815 $3.03 Million
Q1 2024 Apr 29, 2024	BUY	$72.54 - $95.56 $245,983 - $324,043	3,391 Added 12.21%	31,157 $2.98 Million
Q4 2023 Jan 29, 2024	BUY	$61.71 - $77.76 $10,490 - $13,219	170 Added 0.62%	27,766 $2.12 Million
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $41,845 - $56,401	604 Added 2.24%	27,596 $1.91 Million
Q2 2023 Aug 04, 2023	SELL	$81.41 - $94.33 $41,274 - $47,825	-507 Reduced 1.84%	26,992 $2.55 Million
Q1 2023 May 01, 2023	SELL	$74.26 - $84.51 $4,307 - $4,901	-58 Reduced 0.21%	27,499 $2.28 Million
Q4 2022 Jan 31, 2023	BUY	$68.3 - $87.44 $31,418 - $40,222	460 Added 1.7%	27,557 $2.06 Million
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $27,429 - $35,727	333 Added 1.24%	27,097 $2.24 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $5,882 - $8,722	68 Added 0.25%	26,764 $2.55 Million
Q1 2022 May 09, 2022	SELL	$101.96 - $128.34 $98,493 - $123,976	-966 Reduced 3.49%	26,696 $3.14 Million
Q4 2021 Jan 27, 2022	BUY	$106.37 - $130.68 $24,252 - $29,795	228 Added 0.83%	27,662 $3.58 Million
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $30,152 - $35,965	293 Added 1.08%	27,434 $3.11 Million
Q2 2021 Aug 04, 2021	BUY	$83.84 - $104.76 $27,415 - $34,256	327 Added 1.22%	27,141 $2.27 Million
Q2 2021 Aug 04, 2021	SELL	$83.84 - $104.76 $27,415 - $34,256	-327 Reduced 1.2%	26,814 $2.78 Million
Q1 2021 Apr 29, 2021	SELL	$78.68 - $90.67 $207,636 - $239,278	-2,639 Reduced 8.86%	27,141 $2.27 Million
Q4 2020 Jan 28, 2021	SELL	$71.69 - $91.23 $6,452 - $8,210	-90 Reduced 0.3%	29,780 $2.72 Million
Q3 2020 Nov 09, 2020	SELL	$67.19 - $87.44 $25,800 - $33,576	-384 Reduced 1.27%	29,870 $2.38 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $1.74 Million - $2.33 Million	30,254 New	30,254 $2.09 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Seascape Capital Management with notifications on news.

Account

Seascape Capital Management Edwards Lifesciences Corp Transaction History